Groups | Cases | HE4 | ANXA2 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | + | ++ | +++ | Positive cases | Positive rate (%) | - | + | ++ | +++ | Positive cases | Positive rate (%) | ||
Malignant | 50 | 11 | 6 | 16 | 17 | 39 | 78.00* | 12 | 5 | 19 | 14 | 38 | 76.00# |
Mucinous | 20 | 3 | 4 | 6 | 7 | 17 | 85.00 | 2 | 4 | 10 | 4 | 18 | 90.00 |
serous | 30 | 8 | 2 | 10 | 10 | 22 | 73.33 | 10 | 1 | 9 | 10 | 20 | 66.67 |
Borderline | 27 | 12 | 5 | 6 | 4 | 15 | 55.56** | 13 | 5 | 6 | 3 | 14 | 51.85## |
Benign | 15 | 12 | 3 | 0 | 0 | 3 | 20 | 12 | 2 | 1 | 0 | 3 | 20 |
Normal | 15 | 15 | 0 | 0 | 0 | 0 | 0 | 15 | 0 | 0 | 0 | 0 | 0 |